The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Effectiveness and Tolerability of Open Label Olanzapine in Children and Adolescents with Tourette Syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there are preliminary data for olanzapine, 129[ut],131 [ct] aripiprazole 145[cs] and risperidone, 146[cs] in reducing disruptive behavior disorder symptoms, these findings should be interpreted cautiously given significant design limitations, small samples, relatively weak effects, and risks associated with these medications.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [129]
In the citing paper
“In these trials, although olanzapine resulted in a decrease in both tics and aggression, there was a mean increase in weight of 9 to 12 pounds.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Wood, J. J., Piacentini, J. C., Bergman, R. L., McCracken, J., & Barrios, V. (2002) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3103_05 · Cited by 594
Self-citationA placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Research works printed but not linked: 15
- 10.4088/JCP.v62n0412 · DOI
- 10.1097/chi.0b013e31815b5cb1 · DOI · Paper page
- 10.1038/sj.mp.4000581 · DOI
- 10.1017/S0012162200000839 · DOI · Paper page
- 10.1097/00004583-200203000-00013 · DOI · Paper page
- 10.1097/00004583-200402000-00017 · DOI
- 10.1097/00004583-200005000-00007 · DOI · Paper page
- 10.1097/00004583-198907000-00015 · DOI · Paper page
- 10.1177/08830738060210081001 · DOI · Paper page
- 10.1097/00004583-200108000-00009 · DOI · Paper page
- 10.1097/01.chi.0000163279.39598.44 · DOI · Paper page
- 10.1097/00004583-200003000-00010 · DOI · Paper page
- 10.1176/appi.ajp.158.7.1067 · DOI · Paper page
- 10.1089/1044546041648959 · DOI · Paper page
- 10.1207/153744202760082595 · DOI · Paper page
Cited by
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Treatment strategies for tics in Tourette syndrome
Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610390261 · Cited by 158
Milstein, J. A., Elnabawi, A., Vinish, M., Swanson, T., Enos, J. K., Bailey, A. M., Kolb, B., & Frost, D. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057308 · Cited by 57
Metadata
- Authors
- McCracken, J. T., Suddath, R., Chang, S., Thakur, S., & Piacentini, J.
- Affiliations
- Division of Child and Adolescent Psychiatry, UCLA Neuropsychiatric Institute and David Geffen School of Medicine, Los Angeles, California.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-10
- Volume
- 18
- Issue
- 5
- Pages
- 501-508
- ISSN
- 1044-5463
- 1557-8992
- Cited by
- 68
- References
- 3
- Language
- en
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness and Tolerability of Open Label Olanzapine in Children and Adolescents with Tourette Syndrome. https://app.cochat.ai/papers/10.1089/cap.2007.135
- The paper
- McCracken, J. T., Suddath, R., Chang, S., Thakur, S., & Piacentini, J. (2008). Effectiveness and Tolerability of Open Label Olanzapine in Children and Adolescents with Tourette Syndrome. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2007.135
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.